Alopecia Areata Reframed as a Medical Disease, Not a Cosmetic Concern
Dermatology Times reframes alopecia areata as a medical, autoimmune disease, outlining how clinicians should define severity and match treatment options accordingly.
Topic
Treatment Selection
Topic
Treatment Selection
Topical or Oral JAK Inhibitors for Vitiligo: The Choice Problem
Dermatology Times examines how clinicians should choose between topical and oral JAK inhibitors for vitiligo as systemic options…
How Clinicians Are Choosing Among Atopic Dermatitis Biologics
Raj Chovatiya, MD, PhD, outlines how clinicians select among atopic dermatitis biologics absent head-to-head comparative trial da…
Walter Liszewski, MD, on Choosing Atopic Dermatitis Treatments
Walter Liszewski, MD, outlines the patient-specific factors that should guide atopic dermatitis therapy selection in a new HCPLiv…
Fall Clinical Derm 2026: Hsiao Maps First-Line Biologic Choice in HS
At Fall Clinical Derm 2026, Jennifer Hsiao, M.D. laid out recommendations for choosing a first biologic in hidradenitis suppurati…
Jennifer Hsiao, MD, on Hidradenitis Suppurativa Treatment Selection
Jennifer Hsiao, MD, shares practical tips on HS treatment selection and comorbidity screening in a new Dermatology Times conversa…
Evaluating Treatment Selection in Psoriasis
HCPLive's new report examines how dermatologists weigh efficacy, safety, comorbidities, and payer constraints when selecting amon…